Penny Stock Pick Alerts

Sign up today to get profile alerts to your mobile phone before we post them to our site!!

sms
   
 
 

 GOVX.PK
 www.geovax.com 		Geovax HIV/AIDS Vaccines:
img Are currently in Human Clinical Trials across the USA, at major universities
img Are Designed for Predominant AIDS Virus Subtypes
img Use DNA & Viral Vector Technologies
img Demonstrated Excellent Preclinical Results: near 100% protection
img Completed Satisfactory Phase I Human Trial with prototype DNA Vaccine

Vaccines:
img The most cost effective way to combat Infectious Diseases
img Large global AIDS Vaccine Market - $10 billion plus……
img Customers: humans, all ages, sexes, races, nationalities, geographical regions

**We own shares in this company
 
 
Penny Stock Pick Alerts to your phone!
 
*Disclaimer: The smsstockpicks.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by Drinnis Holdings Inc. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication. From time to time Drinnis Holdings Inc sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
 
 All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. Click Here to Learn More ::::